← Open Payments lookup

JEAN WELSH: Open Payments

NPI 1861592461 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,359 in 91 payments from 23 companies in 2025. Trend: 2023 $3,101 · 2024 $2,294 · 2025 $2,359

Food & beverage: $2,339Education: $20
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP9$454
Novo Nordisk Inc7$218
Ardelyx, Inc.8$215
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$195
Gilead Sciences, Inc.7$172
Bayer Healthcare Pharmaceuticals Inc.5$133
Boehringer Ingelheim Pharmaceuticals, Inc.6$121
Lilly USA, LLC5$120
Amgen Inc.6$118
Cumberland Pharmaceuticals, Inc.3$75

Products named: AIRSUPRA, IBSRELA, CAPLYTA, Ozempic, Kerendia, JARDIANCE, MOUNJARO, OTEZLA.

Industry payments across MD — which companies pay providers there.